0 Reacties
0 aandelen
109 Views
0 voorbeeld
Zoeken
Ontdek nieuwe mensen, nieuwe verbindingen te maken en nieuwe vrienden maken
-
Please log in to like, share and comment!
-
Cell and Gene Therapy CDMO: The Future of Gene Therapy ManufacturingThe development and manufacturing of gene therapies have been revolutionized by the emergence of contract development and manufacturing organizations (CDMOs), which provide specialized expertise and infrastructure for vector production. Cell and gene therapy CDMOs enable biopharmaceutical companies to access the capabilities needed to bring gene therapies to market, accelerating the translation...0 Reacties 0 aandelen 97 Views 0 voorbeeld
-
Cell and Gene Therapy Manufacturing Market Future Scope, Regulatory Windows and Forecast to 2033A new report titled “Global Cell and Gene Therapy Manufacturing Market Professional Report 2025-2033” has been added by Straits Research to its repository of research reports. The report analyzes and estimates the market on a global, regional, and country level. The report offers data from previous years along with an in-depth analysis from 2025 to 2033 on the basis of revenue (USD...0 Reacties 0 aandelen 1K Views 0 voorbeeld
-
Manufacturing Hope: How Cell and Gene Therapy Manufacturing Is Advancing with CDMO PartnershipsThe Cell and Gene Therapy CDMO Market is experiencing explosive growth as cell and gene therapy manufacturing continues to advance with strategic CDMO partnerships. According to market reports, the global Cell and Gene Therapy CDMO Market was valued at USD 27.34 billion in 2024 and is projected to reach USD 95.6 billion by 2032, exhibiting an impressive CAGR of 16.94% during the...0 Reacties 0 aandelen 266 Views 0 voorbeeld
-
Therapeutic Breakthroughs: How Cell and Gene Therapy Development Is AcceleratingThe Gene Therapy Clinical Trial Service Market is experiencing transformative growth as cell and gene therapy development continues to accelerate with specialized clinical trial services. According to market reports, the global Gene Therapy Clinical Trial Service Market was valued at USD 2.41 billion in 2024 and is projected to reach USD 42.94 billion by 2035, exhibiting an...0 Reacties 0 aandelen 228 Views 0 voorbeeld
-
Transforming Biopharmaceutical Manufacturing Through the Cell and Gene Therapy CDMO MarketThe Cell and Gene Therapy CDMO Market is experiencing rapid transformation, with the market size projected to reach approximately USD 366.93 billion by 2035, highlighting an impressive CAGR of 23.53% from the current valuation of USD 35.89 billion in 2024. This substantial growth can be attributed to the rising demand for personalized medicine and advancements in production technologies. As...0 Reacties 0 aandelen 331 Views 0 voorbeeld
-
Exosomes Market to Reach USD 912.33 Million by 2033, Growing at 14.7% CAGRThe global exosomes market size was valued at USD 265.51 million in 2024 and is anticipated to grow from USD 304.54 million in 2025 to reach USD 912.33 million in 2033, growing at a CAGR of 14.7% during the forecast period (2025–2033). According to Straits Research, this report provides a clear understanding of the Exosomes Market by analyzing its overall structure, key...0 Reacties 0 aandelen 2K Views 0 voorbeeld
-
Global Biopharmaceutical and Bio-CDMO Market Growing at 14.2% CAGR Through 2032According to a new report from Intel Market Research, the global Biopharmaceutical and Bio-CDMO market was valued at USD 25.71 billion in 2024 and is projected to grow from USD 28.95 billion in 2025 to USD 63.88 billion by 2032, exhibiting a robust CAGR of 14.2% during the forecast period (2025–2032). This growth is driven by increasing demand for biologics and biosimilars due to their...0 Reacties 0 aandelen 1K Views 0 voorbeeld
-
United States Sterile Fill-Finish for Cell and Gene Therapies Market Growing at 8.9%According to a new report from Intel Market Research, the United States Sterile Fill-Finish for Cell and Gene Therapies Market was valued at USD 0.54 billion in 2025 and is projected to reach USD 1.04 billion by 2034, growing at a robust CAGR of 8.9% during the forecast period (2025–2034). This expansion is driven by accelerating investments in cell‑and‑gene therapy pipelines, supportive...0 Reacties 0 aandelen 1K Views 0 voorbeeld
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek